Welcome to the Author Digest, August 2026

We hope you find it helpful.

This digest goes out to all active Cochrane authors and will continue to be sent to authors who are opted in. Please review your communication preferences in your Cochrane Account and ensure you are opted in to communications.

Contents

    1. 2026 submission cut-off period
    2. Do you know of a priority review topic looking for an author team?
    3. Update: Data Sharing policy
    4. 2026 Methods Symposium: Advancing methods for the responsible use of AI in evidence synthesis
    5. Upcoming Methods Support Unit web clinic
    6. New in RevMan
    7. Recent update to the Cochrane review template: reporting excluded studies
    8. Covidence: Spot research integrity concerns earlier
    9. Top tips: ORCiD IDs and publication on the Cochrane Library

1. 2026 submission cut-off period

To help manage year‑end workloads and submission volumes more effectively, the Central Editorial Service will once again apply an annual submission cut‑off for new submissions (this does not apply to proposals or revisions).

This approach reflects standard practice in publishing, recognising the reduced availability of both internal teams and external contributors (e.g., peer reviewers) during the final weeks of the year. As a result, submissions received during this period are often not progressed until the new year.

Key Dates:

  • Final submission date (via Editorial Manager): Monday, 30 November 2026
  • Submissions reopen: Monday, 4 January 2027

We kindly ask authors to plan their submissions accordingly. If you have a valid reason to submit during the cut‑off period, please contact support@cochrane.org. Requests will be considered on a case‑by‑case basis by Cochrane’s Editorial team.

Thank you for your understanding and cooperation.

2. Do you know of a priority review topic looking for an author team?

We're gathering information on review titles that have emerged from priority-setting processes, as well as existing priority Cochrane review titles that currently do not have author teams. This information will help us promote opportunities to the wider community, making it easier to connect important review topics with interested author teams through targeted author calls like this one.

If you know of any relevant titles or would like to discuss further, please get in touch with Roses Parker, Commissioning Editor.

3. Update: Data Sharing policy

In line with our data publishing best practice, Cochrane's data sharing policy has received a small update to clarify that studies should be shared in a way that maximises reuse, including sharing underlying study data alongside analysis datasets. This also aligns with the expectation that new intervention reviews use study-centric data. For more about study centric data in Cochrane reviews, please see the RevMan Knowledge Base.

4. 2026 Methods Symposium: Advancing methods for the responsible use of AI in evidence synthesis

Interested in exploring what evidence is needed to adopt AI tools responsibly in evidence synthesis? Join us in Krakow, Poland at the 2026 Methods Symposium, held on 7 December before the Cochrane Colloquium. This full-day event is jointly hosted by Cochrane Methods Executive and the International Collaboration for the Automation of Systematic Reviews (ICASR).  We’ll hear from experts, such as James Thomas (on RAISE), Georgia Salanti (on RegenAIrate), Carole Lunny, and Gaelen Adams, and engage in thoughtful discussions on this topic and more. Register now and join the conversation!

5. Upcoming Methods Support Unit web clinic

The next MSU web clinic is open for sign-up.  The October clinic focuses on core outcome sets. Don’t forget - if you sign-up, you will automatically be sent a recording of the session afterwards.

Measuring what matters: practical guidance on core outcome sets for systematic review authors: Thursday 1 October: 8am UTC (check time in your time zone)

Sign up here

6. New in RevMan

Dynamic summary of findings tables are moving into a new phase of beta testing. You no longer need to ask us to enable the feature to use it. The RevMan development team is very much looking forward to get your input. So try it out and sign up to share feedback using this form, send an e-mail or book a time slot to chat with us.

We're adding a new field to studies in RevMan so you can mark whether a study is randomized (RCT) or non-randomized (NRSI). This will help ensure the right methods are used during analysis and when assessing certainty of the evidence. Dynamic summary of findings will automatically show number of studies that are RCTs or NRSI. If any included studies haven't been categorized, you'll see a validation warning with a quick-fix option. RevMan will suggest an allocation method for each study based on its methods study characteristics, so you can review and confirm them all in one go rather than doing it one by one. Provisional release date is 3 September.

7. Recent update to the Cochrane review template: reporting excluded studies

Cochrane's review templates contains essential guidance on conducting your review and reporting your findings. Review templates are updated periodically to ensure authors have clear and current guidance on best practice for Cochrane reviews. We therefore advise that authors always open the template as a practice review in RevMan to ensure you are always viewing the latest version. This month, the review templates have been updated based on community feedback with clearer guidance for reporting excluded studies.

8. Covidence: Spot research integrity concerns earlier

Covidence now alerts you if a study has been retracted, has an expression of concern, or is associated with a problematic journal.

Alerts appear directly within your review, helping you identify potential research integrity issues before making inclusion or extraction decisions.

Research integrity alerts are refreshed every 12 hours to help keep your review up to date.

Learn more about this new feature here.

9. Top tips for Cochrane Authors

When submitting your review in Editorial Manager, the corresponding author must include all co-author ORCID IDs if they wish them to be published. Editorial Manager will not pull ORCID IDs from co-author's Editorial Manager accounts. On the Cochrane Library, ORCID IDs on the Cochrane Library will publish as links to the researcher's profile.  

Contact us

If you have any questions about any of the above items, please contact us at support@cochrane.org 

Copyright © 2026 Cochrane, All rights reserved.
Registered in England as a company limited by guarantee No. 03044323 Charity Number 1045921. Registered office: 11-13 Cavendish Square, London, W1G 0AN, United Kingdom

This page uses cookies to offer a better browsing experience, analyze site usage, personalize content, and assist in our marketing efforts. You can change your settings by clicking on "Cookie Preferences."

Cookie Preferences   ▼

This is your setting for either accepting or rejecting cookies on our site. Select to either accept or reject cookies.